Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q99714: Variant p.Arg226Gln

3-hydroxyacyl-CoA dehydrogenase type-2
Gene: HSD17B10
Feedback?
Variant information Variant position: help 226 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Glutamine (Q) at position 226 (R226Q, p.Arg226Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In HSD10MD; strongly decreased 3-hydroxyacyl-CoA dehydrogenase activity; abolished mitochondrial tRNA 5'-end processing; abolished tRNA methylation; impaired homotetramerization. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 226 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 261 The length of the canonical sequence.
Location on the sequence: help LTSLPEKVCNFLASQVPFPS R LGDPAEYAHLVQAIIENPFL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 261 3-hydroxyacyl-CoA dehydrogenase type-2
Modified residue 212 – 212 N6-acetyllysine; alternate
Modified residue 212 – 212 N6-succinyllysine; alternate



Literature citations
Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: difficulties in the diagnosis.
Garcia-Villoria J.; Navarro-Sastre A.; Fons C.; Perez-Cerda C.; Baldellou A.; Fuentes-Castello M.A.; Gonzalez I.; Hernandez-Gonzalez A.; Fernandez C.; Campistol J.; Delpiccolo C.; Cortes N.; Messeguer A.; Briones P.; Ribes A.;
Clin. Biochem. 42:27-33(2009)
Cited for: VARIANTS HSD10MD CYS-130; SER-210; GLN-226 AND SER-247; FUNCTION; CATALYTIC ACTIVITY; Molecular insights into HSD10 disease: impact of SDR5C1 mutations on the human mitochondrial RNase P complex.
Vilardo E.; Rossmanith W.;
Nucleic Acids Res. 43:5112-5119(2015)
Cited for: VARIANTS HSD10MD CYS-130; SER-210; GLN-226 AND SER-247; FUNCTION; CATALYTIC ACTIVITY; SUBUNIT; MUTAGENESIS OF LYS-172; CHARACTERIZATION OF VARIANTS HSD10MD CYS-130; SER-210; GLN-226 AND SER-247;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.